Miria Chitukuta

Biographic Data

ID	4720626
NAME	Miria Chitukuta
GIVEN NAMES	Miria
FAMILY NAME	Chitukuta
SIGNATURE	CHITUKUTA M
AFFILIATIONS	University of Zimbabwe
ORCID	0000-0002-7345-0251
VERIFIED	Yes
TOTAL WORKS	15
TOTAL CITATIONS	2
WORKS AS AUTHOR	15
WORKS AS EDITOR	0
FIRST PUBLICATION YEAR	2017
LATEST PUBLICATION YEAR	2025
H-INDEX	1

Motivations for Starting and Stopping PrEP
Open AccessLisa Mills, Nomhle Khoza et al.ARTICLEAIDS and Behavior2025
Oral PrEP effectiveness depends on consistent use during periods of potential HIV exposure, but adolescent girls and young women (AGYW) find this challenging. Data on PrEP use decision-making and alignment with risk among AGYW are limited. From 2016 to 2018, we conducted in-depth interviews with participants in HPTN 082, an open-label PrEP study in South Africa and Zimbabwe, to explore reasons for PrEP starts, stops, and restarts. Of 60 PrEP acce…
Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex
Erica N Browne, Kristine Torjesen et al.ARTICLEAIDS Care2024
We assessed if acceptability of the dapivirine vaginal ring for HIV prevention differed among the subgroup of women who reported engaging in transactional sex prior to enrollment in MTN-020/ASPIRE (phase III trial in Malawi, South Africa, Uganda, and Zimbabwe, 2012-2015; n = 2629). Transactional sex was defined as receipt of money, goods, gifts, drugs, or shelter in exchange for sex in the past year. Dimensions of acceptability included: ease of …
“We chose PrEP because I wanted to be sure that this child my wife was going to conceive was indeed mine.” Factors influencing the choice of safer conception methods and experiences with its use
Open AccessJoelle Brown, Joelle M Brown et al.ARTICLEBMC Public Health2024
The differences in method preferences and experiences voiced by participants in this study and in other studies from the region point to the importance of having a variety of safer conception options in the service delivery package and addressing concerns about paternity, intimacy, and method-related attributes to enable HIV sero-discordant couples to safely achieve their reproductive goals
Adolescent Girls and Young Women’s Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use
Open AccessAlinda M Young, Noah Mancuso et al.ARTICLEAIDS and Behavior2023
Effective use of oral pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in Eastern and Southern Africa, partly due to stigma and opposition from key influencers. Understanding AGYW's experiences of disclosure of different PrEP modalities to key influencers may inform strategies to motivate uptake and adherence. We analyzed qualitative in-depth interviews and focus group discussions data from 119 participan…
Ring-ing in the Future
Open AccessKrishnaveni Reddy, Florence Mathebula et al.ARTICLEAIDS and Behavior2022
Religious leaders’ role in pregnant and breastfeeding women’s decision making and willingness to use biomedical HIV prevention strategies
Alinda M Young, Julia Ryan et al.ARTICLECulture Health & Sexuality2022
Oral Pre-Exposure Prophylaxis (PrEP) is an established option, and the dapivirine vaginal ring is emerging as a promising strategy for HIV prevention option for women. Because of this, understanding the contextual and cultural factors that will support the increased uptake of these products is crucial. In sub-Saharan Africa, religious leaders may be important stakeholders to involve in product information, education and roll-out. We conducted a s…
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial
Open AccessAshley Mayo, Erica N Browne et al.ARTICLEAIDS and Behavior2021
We evaluated the acceptability of the 25 mg dapivirine vaginal ring (DVR) as an HIV prevention intervention and its influence on DVR adherence in the MTN-020/ASPIRE phase III trial. Acceptability measures were captured using ACASI at month 3 and end of product use (median 24 months, IQR 15-30). Monthly returned rings were classified as nonadherent if dapivirine release rate was ≤ 0.9 mg/month. Associations between acceptability measures and nonad…
Men’s Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe
Open AccessElizabeth Montgomery, Ariana Katz et al.ARTICLEAIDS and Behavior2021
The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence
Open AccessMarie C D Stoner, Elizabeth R Brown et al.ARTICLEAIDS and Behavior2021
The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082
Open AccessJennifer Velloza, Nomhle Khoza et al.ARTICLEJournal of the International AIDS…2020
After their wives have delivered, a lot of men like going out
Open AccessValerie L Flax, Imogen Hawley et al.ARTICLEMaternal and Child Nutrition2020
Female-initiated HIV prevention methods, such as oral pre-exposure prophylaxis (PrEP) and the vaginal ring, may be important risk reduction strategies for breastfeeding women. Given their novelty, information about the sociocultural context and how it influences perceptions of and support for their use during breastfeeding is lacking. To address this gap, we conducted 23 focus group discussions separately with pregnant and breastfeeding women, ma…
The Power of the Shared Experience
Open AccessAriana Katz, Kalendri Naidoo et al.ARTICLEAIDS and Behavior2020
Narrative sexual histories and perceptions of HIV risk among young women taking PrEP in southern Africa
Open AccessF Scorgie, Nomhle Khoza et al.ARTICLESocial Science & Medicine2020Cited by: 2References: 1
Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa
Miria Chitukuta, Zoe Duby et al.ARTICLECulture Health & Sexuality2019
Rumours may influence health-related behaviours, including the uptake of and adherence to HIV prevention products. This study assessed the safety and effectiveness of a vaginal ring delivering the antiretroviral dapivirine for HIV prevention in Africa. We explored negative rumours about study participation and the vaginal ring amongst study participants and their communities in Malawi, Uganda, South Africa and Zimbabwe. In total 214 women partici…
Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial
Open AccessOn behalf of the MTN-020/ASPIRE Study Team, Nicole Laborde et al.ARTICLEAIDS and Behavior2017